Abiopharma

🔍 Bragg Kimberly (Executive)

Company: Imunon, Inc. (IMNN)

Report Date: 2026-01-02

Detailed Transactions and Holdings:

• Acquired 9,050 shares of Stock Option (Right to Buy) at $3.95 per share (Derivative)
  Date: 2026-01-02 | Code: A | Expires: 2036-01-02 | Exercise: 2026-01-02 | equity_swap_involved: 0 | shares_owned_after: 9,050.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: Represents the closing price of Imunon, Inc. Common Stock on the date of the grant
• F2: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant.